Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis

[1] Bohn B(2017)Standards of medical care in diabetes—2017 Diabetes Care 40 S1-S135

[2] Karges B(2016)20 years of pediatric benchmarking in Germany and Austria: age-dependent analysis of longitudinal follow-up in 63,967 children and adolescents with type 1 diabetes PLoS One 11 e0160971-438

[3] Vogel C(2011)Special considerations with insulin therapy in older adults with diabetes mellitus Drugs Aging 28 429-1606

[4] Mooradian AD(2013)Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review J Diabetes Sci Technol. 7 1595-788

[5] Kerr D(2012)The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences Diabetes Obes Metab 14 780-2054

[6] Wizemann E(2014)Type 1 diabetes through the life span: a position statement of the American Diabetes Association Diabetes Care 37 2034-e7

[7] Senstius J(2008)Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects Am J Obstet Gynecol 198 e1-776

[8] Zacho M(2007)Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women Diabetes Care 30 771-121

[9] Ampudia-Blasco FJ(2002)Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus Diabetes Res Clin Pract 58 115-24

[10] Home PD(2007)Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin Diabetes Care 30 e11-1135

[1] Bohn B(2017)Standards of medical care in diabetes—2017 Diabetes Care 40 S1-S135

[2] Karges B(2016)20 years of pediatric benchmarking in Germany and Austria: age-dependent analysis of longitudinal follow-up in 63,967 children and adolescents with type 1 diabetes PLoS One 11 e0160971-438

[3] Vogel C(2011)Special considerations with insulin therapy in older adults with diabetes mellitus Drugs Aging 28 429-1606

[4] Mooradian AD(2013)Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review J Diabetes Sci Technol. 7 1595-788

[5] Kerr D(2012)The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences Diabetes Obes Metab 14 780-2054

[6] Wizemann E(2014)Type 1 diabetes through the life span: a position statement of the American Diabetes Association Diabetes Care 37 2034-e7

[7] Senstius J(2008)Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects Am J Obstet Gynecol 198 e1-776

[8] Zacho M(2007)Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women Diabetes Care 30 771-121

[9] Ampudia-Blasco FJ(2002)Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus Diabetes Res Clin Pract 58 115-24

[10] Home PD(2007)Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin Diabetes Care 30 e11-1135